| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5932244 | The American Journal of Pathology | 2016 | 7 Pages |
Abstract
Three key elements to precision medicine are stratification by risk, detection of pathophysiological processes as early as possible (even before clinical presentation), and alignment of mechanism of action of intervention(s) with an individual's molecular driver(s) of disease. Used for decades in the management of some rare diseases and now gaining broad currency in cancer care, a precision medicine approach is beginning to be adapted to cognitive impairment and dementia. This review focuses on the application of precision medicine to address the clinical and biological complexity of two common neurodegenerative causes of dementia: Alzheimer disease and Parkinson disease.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Brenna Cholerton, Eric B. Larson, Joseph F. Quinn, Cyrus P. Zabetian, Ignacio F. Mata, C. Dirk Keene, Margaret Flanagan, Paul K. Crane, Thomas J. Grabowski, Kathleen S. Montine, Thomas J. Montine,